| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leptin | 91 | 2024 | 1591 | 5.250 |
Why?
|
| Insulin | 88 | 2023 | 6578 | 2.450 |
Why?
|
| Obesity | 86 | 2024 | 12870 | 2.300 |
Why?
|
| Energy Metabolism | 34 | 2017 | 2868 | 1.950 |
Why?
|
| Hypothalamus | 28 | 2013 | 998 | 1.940 |
Why?
|
| Biomedical Research | 10 | 2023 | 3417 | 1.840 |
Why?
|
| Adipose Tissue | 55 | 2014 | 3299 | 1.820 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 16 | 2010 | 173 | 1.720 |
Why?
|
| Insulin Resistance | 58 | 2020 | 3941 | 1.610 |
Why?
|
| Receptor, Insulin | 56 | 2006 | 833 | 1.510 |
Why?
|
| Proteins | 50 | 2006 | 6026 | 1.500 |
Why?
|
| Adipocytes | 26 | 2011 | 1177 | 1.420 |
Why?
|
| Academies and Institutes | 3 | 2023 | 319 | 1.400 |
Why?
|
| Fibroblast Growth Factors | 16 | 2019 | 867 | 1.340 |
Why?
|
| Adipose Tissue, Brown | 20 | 2020 | 755 | 1.240 |
Why?
|
| Receptors, Cell Surface | 28 | 2006 | 2825 | 1.230 |
Why?
|
| Awards and Prizes | 4 | 2019 | 359 | 1.150 |
Why?
|
| Research Personnel | 4 | 2023 | 582 | 1.150 |
Why?
|
| Monosaccharide Transport Proteins | 22 | 1996 | 436 | 0.900 |
Why?
|
| Endocrinology | 2 | 2021 | 441 | 0.900 |
Why?
|
| Eating | 21 | 2008 | 1536 | 0.880 |
Why?
|
| Publishing | 2 | 2023 | 833 | 0.860 |
Why?
|
| Carrier Proteins | 25 | 2005 | 4937 | 0.830 |
Why?
|
| Receptors, Leptin | 21 | 2011 | 350 | 0.800 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2024 | 362 | 0.750 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 20052 | 0.740 |
Why?
|
| Dietary Fats | 17 | 2016 | 1991 | 0.740 |
Why?
|
| Animals | 193 | 2021 | 167777 | 0.700 |
Why?
|
| Peptide Hormones | 4 | 2005 | 132 | 0.700 |
Why?
|
| Scientific Misconduct | 1 | 2021 | 74 | 0.690 |
Why?
|
| Credentialing | 1 | 2020 | 115 | 0.660 |
Why?
|
| RNA, Messenger | 65 | 2014 | 12760 | 0.660 |
Why?
|
| Biology | 2 | 2019 | 289 | 0.650 |
Why?
|
| Homeostasis | 16 | 2020 | 3302 | 0.620 |
Why?
|
| Health Occupations | 1 | 2020 | 222 | 0.610 |
Why?
|
| Body Weight | 29 | 2012 | 4603 | 0.610 |
Why?
|
| Manuscripts as Topic | 1 | 2017 | 15 | 0.600 |
Why?
|
| Nobel Prize | 2 | 2021 | 48 | 0.600 |
Why?
|
| Signal Transduction | 35 | 2017 | 23341 | 0.600 |
Why?
|
| Receptors, Adrenergic, beta | 9 | 2015 | 240 | 0.600 |
Why?
|
| Mice, Obese | 20 | 2011 | 420 | 0.590 |
Why?
|
| Mice | 115 | 2019 | 81107 | 0.570 |
Why?
|
| Glucose | 24 | 2020 | 4336 | 0.570 |
Why?
|
| Neurons | 17 | 2011 | 9418 | 0.560 |
Why?
|
| Drug Industry | 2 | 2024 | 787 | 0.550 |
Why?
|
| Appetite | 6 | 2017 | 247 | 0.550 |
Why?
|
| Career Mobility | 1 | 2019 | 258 | 0.540 |
Why?
|
| Diabetes Mellitus | 23 | 2019 | 5818 | 0.540 |
Why?
|
| Transcription Factors | 25 | 2012 | 12096 | 0.540 |
Why?
|
| Neuropeptide Y | 11 | 2005 | 191 | 0.520 |
Why?
|
| Adipose Tissue, White | 5 | 2015 | 365 | 0.520 |
Why?
|
| Repressor Proteins | 11 | 2004 | 2980 | 0.520 |
Why?
|
| Authorship | 1 | 2019 | 281 | 0.510 |
Why?
|
| Peer Review | 1 | 2017 | 217 | 0.500 |
Why?
|
| Schools, Medical | 2 | 2023 | 877 | 0.490 |
Why?
|
| PPAR gamma | 3 | 2007 | 482 | 0.480 |
Why?
|
| Pro-Opiomelanocortin | 6 | 2006 | 140 | 0.480 |
Why?
|
| Acanthosis Nigricans | 14 | 1994 | 47 | 0.470 |
Why?
|
| History, 20th Century | 5 | 2024 | 2772 | 0.470 |
Why?
|
| Energy Intake | 11 | 2011 | 2127 | 0.470 |
Why?
|
| Faculty | 1 | 2017 | 383 | 0.460 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2019 | 791 | 0.460 |
Why?
|
| Appetite Regulation | 4 | 2017 | 84 | 0.450 |
Why?
|
| Gene Expression | 17 | 2007 | 7583 | 0.440 |
Why?
|
| Gene Expression Regulation | 35 | 2016 | 11894 | 0.440 |
Why?
|
| Ciliary Neurotrophic Factor | 5 | 2007 | 77 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 44 | 2018 | 22006 | 0.430 |
Why?
|
| Hydroxysteroid Dehydrogenases | 2 | 2003 | 29 | 0.420 |
Why?
|
| Mice, Knockout | 27 | 2019 | 14354 | 0.410 |
Why?
|
| Conflict of Interest | 1 | 2017 | 548 | 0.400 |
Why?
|
| Serine Endopeptidases | 9 | 1995 | 1020 | 0.400 |
Why?
|
| Glucocorticoids | 5 | 2005 | 2144 | 0.380 |
Why?
|
| Disclosure | 1 | 2017 | 738 | 0.380 |
Why?
|
| Drug Discovery | 1 | 2019 | 1044 | 0.380 |
Why?
|
| Sympathetic Nervous System | 4 | 2017 | 518 | 0.380 |
Why?
|
| Liver | 25 | 2019 | 7502 | 0.370 |
Why?
|
| Fatty Acids | 4 | 2014 | 1803 | 0.370 |
Why?
|
| Thyrotropin-Releasing Hormone | 6 | 2001 | 139 | 0.360 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2010 | 95 | 0.360 |
Why?
|
| Lipase | 3 | 2009 | 324 | 0.350 |
Why?
|
| Research | 1 | 2019 | 1976 | 0.350 |
Why?
|
| Physiology | 1 | 2010 | 111 | 0.350 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 8 | 2004 | 855 | 0.350 |
Why?
|
| Neuropeptides | 6 | 2007 | 943 | 0.350 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 3 | 2004 | 21 | 0.340 |
Why?
|
| Polycystic Ovary Syndrome | 7 | 1997 | 376 | 0.340 |
Why?
|
| Diabetes Mellitus, Type 1 | 8 | 2021 | 3432 | 0.330 |
Why?
|
| Starvation | 5 | 2006 | 140 | 0.330 |
Why?
|
| Fasting | 14 | 2016 | 1599 | 0.330 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 41 | 0.330 |
Why?
|
| Receptors, Corticotropin | 4 | 2003 | 24 | 0.330 |
Why?
|
| Panniculitis | 1 | 2009 | 45 | 0.320 |
Why?
|
| Immediate-Early Proteins | 4 | 2004 | 449 | 0.320 |
Why?
|
| Faculty, Medical | 1 | 2017 | 1192 | 0.310 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2008 | 45 | 0.310 |
Why?
|
| Chemokines, CXC | 5 | 2001 | 421 | 0.310 |
Why?
|
| Hypothalamus, Middle | 3 | 2011 | 15 | 0.310 |
Why?
|
| Mitochondrial Proteins | 12 | 2015 | 977 | 0.310 |
Why?
|
| Animal Nutritional Physiological Phenomena | 2 | 2000 | 56 | 0.300 |
Why?
|
| Corticosterone | 9 | 2003 | 305 | 0.300 |
Why?
|
| Humans | 175 | 2024 | 758381 | 0.300 |
Why?
|
| Protein Biosynthesis | 9 | 2007 | 2105 | 0.290 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2007 | 99 | 0.290 |
Why?
|
| Blood Glucose | 26 | 2021 | 6347 | 0.290 |
Why?
|
| History, 21st Century | 3 | 2021 | 1573 | 0.290 |
Why?
|
| STAT3 Transcription Factor | 8 | 2008 | 869 | 0.290 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2006 | 1651 | 0.280 |
Why?
|
| Peer Review, Research | 2 | 2023 | 340 | 0.280 |
Why?
|
| Ion Channels | 13 | 2015 | 1043 | 0.280 |
Why?
|
| 3T3-L1 Cells | 6 | 2007 | 209 | 0.280 |
Why?
|
| Tumor Necrosis Factor-alpha | 11 | 2016 | 4342 | 0.280 |
Why?
|
| Diphtheria Toxin | 6 | 1998 | 252 | 0.280 |
Why?
|
| Weight Gain | 6 | 2010 | 2346 | 0.280 |
Why?
|
| Rats | 42 | 2006 | 23681 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 24 | 2014 | 12076 | 0.270 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 1996 | 39 | 0.270 |
Why?
|
| Hunger | 2 | 2005 | 206 | 0.270 |
Why?
|
| Mice, Transgenic | 18 | 2011 | 9518 | 0.260 |
Why?
|
| Health Personnel | 1 | 2020 | 3311 | 0.260 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 7 | 1984 | 477 | 0.260 |
Why?
|
| Recombinant Proteins | 17 | 2014 | 6520 | 0.260 |
Why?
|
| Somatomedins | 7 | 1993 | 178 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 12 | 2010 | 5779 | 0.260 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2005 | 18 | 0.250 |
Why?
|
| Insulin-Like Growth Factor I | 7 | 1995 | 1927 | 0.250 |
Why?
|
| Adult Stem Cells | 1 | 2007 | 221 | 0.250 |
Why?
|
| Hypothalamic Hormones | 6 | 2004 | 145 | 0.250 |
Why?
|
| Pituitary Hormones | 6 | 2004 | 182 | 0.250 |
Why?
|
| Membrane Proteins | 13 | 2011 | 7843 | 0.250 |
Why?
|
| Weight Loss | 4 | 2017 | 2671 | 0.250 |
Why?
|
| Transcription, Genetic | 18 | 2006 | 7590 | 0.250 |
Why?
|
| alpha-MSH | 7 | 2003 | 71 | 0.240 |
Why?
|
| Hypoglycemic Agents | 5 | 2024 | 3069 | 0.240 |
Why?
|
| Leucine | 1 | 2006 | 547 | 0.240 |
Why?
|
| Chemokine CCL2 | 1 | 2007 | 604 | 0.240 |
Why?
|
| Nuclear Proteins | 7 | 2006 | 5787 | 0.240 |
Why?
|
| Protein-Tyrosine Kinases | 11 | 2000 | 2416 | 0.230 |
Why?
|
| Lipodystrophy | 3 | 2003 | 148 | 0.230 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 3 | 2002 | 286 | 0.230 |
Why?
|
| Hormones | 6 | 2000 | 869 | 0.230 |
Why?
|
| Melanins | 6 | 2004 | 289 | 0.230 |
Why?
|
| Trans-Activators | 8 | 2012 | 2860 | 0.230 |
Why?
|
| Nucleus Accumbens | 1 | 2006 | 365 | 0.230 |
Why?
|
| Cricetinae | 13 | 2000 | 2426 | 0.220 |
Why?
|
| Hypothalamic Area, Lateral | 3 | 1999 | 105 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2000 | 1245 | 0.220 |
Why?
|
| Complement Factor D | 10 | 2014 | 66 | 0.220 |
Why?
|
| Endocrine System | 1 | 2004 | 112 | 0.220 |
Why?
|
| Endocrine Glands | 3 | 2000 | 101 | 0.220 |
Why?
|
| Thiazolidinediones | 4 | 2007 | 460 | 0.210 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2006 | 577 | 0.210 |
Why?
|
| Lipid Metabolism | 5 | 2014 | 1894 | 0.210 |
Why?
|
| Cell Differentiation | 7 | 2012 | 11471 | 0.210 |
Why?
|
| Triiodothyronine | 5 | 2014 | 493 | 0.200 |
Why?
|
| Organizations, Nonprofit | 1 | 2023 | 104 | 0.200 |
Why?
|
| Phosphorylation | 16 | 2011 | 8297 | 0.200 |
Why?
|
| Agouti-Related Protein | 4 | 2006 | 93 | 0.200 |
Why?
|
| DNA-Binding Proteins | 11 | 2004 | 9575 | 0.200 |
Why?
|
| Anti-Obesity Agents | 2 | 2007 | 227 | 0.200 |
Why?
|
| CHO Cells | 10 | 2000 | 1389 | 0.200 |
Why?
|
| Neurosecretory Systems | 3 | 2000 | 221 | 0.200 |
Why?
|
| Organ Specificity | 11 | 2016 | 1955 | 0.190 |
Why?
|
| Malonyl Coenzyme A | 1 | 2001 | 19 | 0.190 |
Why?
|
| Hyperinsulinism | 5 | 2001 | 400 | 0.190 |
Why?
|
| Protein Precursors | 3 | 2000 | 1133 | 0.190 |
Why?
|
| Autoantibodies | 15 | 1992 | 2118 | 0.190 |
Why?
|
| Research Design | 4 | 2017 | 6154 | 0.190 |
Why?
|
| Hormones, Ectopic | 1 | 2001 | 37 | 0.190 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2001 | 72 | 0.190 |
Why?
|
| Carbohydrates | 1 | 2023 | 388 | 0.190 |
Why?
|
| Muscle Proteins | 3 | 1996 | 1150 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2011 | 4567 | 0.180 |
Why?
|
| Muscle, Skeletal | 10 | 2014 | 4902 | 0.180 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2000 | 4485 | 0.180 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2020 | 14 | 0.180 |
Why?
|
| Male | 106 | 2018 | 358742 | 0.180 |
Why?
|
| Intestines | 1 | 2009 | 1906 | 0.180 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2020 | 344 | 0.180 |
Why?
|
| Fibroblasts | 11 | 2004 | 4087 | 0.180 |
Why?
|
| Fraud | 1 | 2021 | 66 | 0.180 |
Why?
|
| Health Care Reform | 1 | 2009 | 1245 | 0.180 |
Why?
|
| Base Sequence | 24 | 2003 | 12436 | 0.180 |
Why?
|
| Receptors, Adrenergic, beta-3 | 6 | 2015 | 62 | 0.170 |
Why?
|
| Adiposity | 2 | 2009 | 1858 | 0.170 |
Why?
|
| Protein Kinases | 2 | 2006 | 1610 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 17 | 2004 | 8144 | 0.170 |
Why?
|
| Hypothalamo-Hypophyseal System | 7 | 1998 | 700 | 0.170 |
Why?
|
| Molecular Sequence Data | 26 | 2001 | 17617 | 0.170 |
Why?
|
| Brain Chemistry | 2 | 2002 | 959 | 0.170 |
Why?
|
| Cells, Cultured | 22 | 2012 | 18942 | 0.170 |
Why?
|
| Dermatitis | 1 | 2001 | 200 | 0.170 |
Why?
|
| PPAR alpha | 3 | 2011 | 175 | 0.170 |
Why?
|
| Rats, Zucker | 2 | 1998 | 131 | 0.170 |
Why?
|
| Serial Publications | 1 | 2019 | 11 | 0.160 |
Why?
|
| Dopamine | 1 | 2006 | 1599 | 0.160 |
Why?
|
| Muscles | 9 | 2006 | 1579 | 0.160 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1996 | 489 | 0.160 |
Why?
|
| Brain | 13 | 2005 | 26951 | 0.160 |
Why?
|
| In Situ Hybridization | 9 | 2001 | 1900 | 0.160 |
Why?
|
| Erythrocytes | 9 | 1986 | 2413 | 0.160 |
Why?
|
| Gastrointestinal Tract | 1 | 2005 | 830 | 0.160 |
Why?
|
| Acetanilides | 1 | 2020 | 169 | 0.160 |
Why?
|
| Microbodies | 2 | 1997 | 36 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2000 | 459 | 0.160 |
Why?
|
| History, 19th Century | 1 | 2021 | 720 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 4 | 1999 | 4406 | 0.150 |
Why?
|
| Tyrosine | 6 | 2004 | 1432 | 0.150 |
Why?
|
| Receptors, Chemokine | 1 | 2001 | 655 | 0.150 |
Why?
|
| Lipolysis | 3 | 2011 | 209 | 0.150 |
Why?
|
| Gastric Bypass | 2 | 2007 | 817 | 0.150 |
Why?
|
| Editorial Policies | 1 | 2023 | 456 | 0.150 |
Why?
|
| Adaptation, Physiological | 2 | 2017 | 1295 | 0.150 |
Why?
|
| Sleep Deprivation | 1 | 2004 | 840 | 0.150 |
Why?
|
| Ghrelin | 3 | 2004 | 251 | 0.150 |
Why?
|
| Nutrition Disorders | 1 | 1998 | 205 | 0.150 |
Why?
|
| Syndrome | 15 | 1995 | 3262 | 0.150 |
Why?
|
| Amino Acid Sequence | 17 | 1999 | 13447 | 0.150 |
Why?
|
| Patents as Topic | 1 | 2019 | 111 | 0.150 |
Why?
|
| Thiazoles | 3 | 2020 | 1511 | 0.140 |
Why?
|
| Mutation | 15 | 2010 | 29915 | 0.140 |
Why?
|
| Pituitary-Adrenal System | 2 | 1997 | 552 | 0.140 |
Why?
|
| Retraction of Publication as Topic | 1 | 2016 | 10 | 0.140 |
Why?
|
| Interdisciplinary Studies | 1 | 2017 | 86 | 0.140 |
Why?
|
| Receptors, Adrenergic | 1 | 2017 | 155 | 0.140 |
Why?
|
| Insurance, Health | 1 | 2009 | 2495 | 0.140 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 4 | 2004 | 114 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 5 | 2006 | 1111 | 0.140 |
Why?
|
| Thyroid Gland | 4 | 2000 | 1168 | 0.140 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 2016 | 20 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 16 | 1999 | 6068 | 0.140 |
Why?
|
| Dogs | 2 | 2021 | 3838 | 0.140 |
Why?
|
| Glucose Tolerance Test | 12 | 2004 | 1172 | 0.140 |
Why?
|
| Isomerism | 4 | 2002 | 197 | 0.140 |
Why?
|
| Ecosystem | 1 | 2021 | 487 | 0.140 |
Why?
|
| Models, Biological | 10 | 2006 | 9461 | 0.140 |
Why?
|
| Bromodeoxyuridine | 2 | 2007 | 311 | 0.130 |
Why?
|
| Biological Science Disciplines | 1 | 2016 | 57 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 3 | 2011 | 1477 | 0.130 |
Why?
|
| Thyroxine | 4 | 2014 | 667 | 0.130 |
Why?
|
| Dioxoles | 1 | 1996 | 95 | 0.130 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 3 | 2008 | 46 | 0.130 |
Why?
|
| Injections, Intraventricular | 4 | 2005 | 225 | 0.130 |
Why?
|
| Axons | 1 | 2004 | 1674 | 0.130 |
Why?
|
| Thermogenesis | 3 | 2015 | 468 | 0.130 |
Why?
|
| Ovary | 6 | 1998 | 958 | 0.130 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 1996 | 86 | 0.130 |
Why?
|
| Peptides | 4 | 2002 | 4341 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2013 | 10417 | 0.130 |
Why?
|
| DNA | 16 | 2003 | 7199 | 0.130 |
Why?
|
| Insulin-Secreting Cells | 3 | 2014 | 896 | 0.130 |
Why?
|
| Cell Line | 18 | 2006 | 15594 | 0.130 |
Why?
|
| Membrane Transport Proteins | 3 | 2004 | 1034 | 0.130 |
Why?
|
| Phorbol Esters | 2 | 1999 | 108 | 0.130 |
Why?
|
| Neuronal Plasticity | 1 | 2004 | 1429 | 0.130 |
Why?
|
| Models, Animal | 2 | 2017 | 2112 | 0.130 |
Why?
|
| Mice, Inbred Strains | 4 | 2007 | 1759 | 0.130 |
Why?
|
| Reproduction | 1 | 2000 | 646 | 0.120 |
Why?
|
| Macrophages | 2 | 2007 | 5737 | 0.120 |
Why?
|
| Fatty Liver | 3 | 2012 | 777 | 0.120 |
Why?
|
| Sexual Maturation | 1 | 1997 | 260 | 0.120 |
Why?
|
| Transfection | 10 | 2007 | 5779 | 0.120 |
Why?
|
| Islets of Langerhans | 2 | 2016 | 1345 | 0.120 |
Why?
|
| Neural Stem Cells | 2 | 2013 | 882 | 0.120 |
Why?
|
| Choline Deficiency | 1 | 2014 | 23 | 0.120 |
Why?
|
| Ligands | 9 | 2006 | 3258 | 0.120 |
Why?
|
| Adipocytes, White | 1 | 2015 | 91 | 0.120 |
Why?
|
| Lipotropic Agents | 1 | 2014 | 13 | 0.120 |
Why?
|
| Hypothyroidism | 2 | 2014 | 665 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2006 | 3046 | 0.120 |
Why?
|
| Cloning, Molecular | 8 | 1999 | 4169 | 0.120 |
Why?
|
| Catecholamines | 1 | 1995 | 385 | 0.110 |
Why?
|
| Cell Size | 2 | 2009 | 623 | 0.110 |
Why?
|
| Ouabain | 7 | 1984 | 247 | 0.110 |
Why?
|
| COS Cells | 3 | 2003 | 1128 | 0.110 |
Why?
|
| Reference Values | 15 | 2002 | 4919 | 0.110 |
Why?
|
| Sex Characteristics | 8 | 1998 | 2621 | 0.110 |
Why?
|
| Cholesterol, HDL | 1 | 2020 | 1808 | 0.110 |
Why?
|
| Kinetics | 17 | 2004 | 6371 | 0.110 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1996 | 435 | 0.110 |
Why?
|
| Receptors, Somatomedin | 7 | 1989 | 56 | 0.110 |
Why?
|
| Thinness | 3 | 2006 | 490 | 0.110 |
Why?
|
| Microcirculation | 1 | 1998 | 1273 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2015 | 1240 | 0.110 |
Why?
|
| Dexamethasone | 2 | 1999 | 1927 | 0.110 |
Why?
|
| Serine | 2 | 2003 | 828 | 0.110 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2013 | 31 | 0.110 |
Why?
|
| Prostaglandin D2 | 2 | 2007 | 108 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2003 | 1973 | 0.110 |
Why?
|
| Confidentiality | 1 | 2017 | 609 | 0.110 |
Why?
|
| Research Support as Topic | 1 | 2017 | 697 | 0.100 |
Why?
|
| Hyperplasia | 1 | 2016 | 1154 | 0.100 |
Why?
|
| Ketosis | 2 | 2009 | 46 | 0.100 |
Why?
|
| Immune Tolerance | 3 | 2008 | 2297 | 0.100 |
Why?
|
| Rubidium | 5 | 1984 | 122 | 0.100 |
Why?
|
| Uncertainty | 1 | 2017 | 751 | 0.100 |
Why?
|
| GTP-Binding Proteins | 2 | 1994 | 950 | 0.100 |
Why?
|
| Osmolar Concentration | 3 | 1997 | 660 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2003 | 2211 | 0.100 |
Why?
|
| Third Ventricle | 1 | 2013 | 74 | 0.100 |
Why?
|
| Hyperthyroidism | 3 | 2014 | 291 | 0.100 |
Why?
|
| Down-Regulation | 2 | 1999 | 2905 | 0.100 |
Why?
|
| Deoxyglucose | 6 | 1995 | 333 | 0.100 |
Why?
|
| Education, Medical | 2 | 2017 | 1725 | 0.100 |
Why?
|
| Methionine | 1 | 2014 | 569 | 0.100 |
Why?
|
| Acromegaly | 2 | 1993 | 306 | 0.100 |
Why?
|
| Diet, Reducing | 3 | 2007 | 485 | 0.100 |
Why?
|
| Female | 79 | 2017 | 390316 | 0.100 |
Why?
|
| Periodicals as Topic | 1 | 2023 | 1462 | 0.100 |
Why?
|
| Feeding Behavior | 3 | 2004 | 3183 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2007 | 1074 | 0.090 |
Why?
|
| Hirsutism | 3 | 1988 | 68 | 0.090 |
Why?
|
| Aging | 6 | 2013 | 8651 | 0.090 |
Why?
|
| Circadian Rhythm | 4 | 2001 | 2567 | 0.090 |
Why?
|
| Ethanol | 1 | 2017 | 1325 | 0.090 |
Why?
|
| Vanadates | 1 | 1990 | 82 | 0.090 |
Why?
|
| Indoles | 1 | 1999 | 1828 | 0.090 |
Why?
|
| Smoking | 2 | 1998 | 9042 | 0.090 |
Why?
|
| Binding, Competitive | 8 | 1998 | 1141 | 0.090 |
Why?
|
| Cycloheximide | 2 | 2007 | 343 | 0.090 |
Why?
|
| Protein Kinase C | 2 | 1999 | 1199 | 0.090 |
Why?
|
| DNA Primers | 6 | 1998 | 2816 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2016 | 473 | 0.090 |
Why?
|
| Keratinocytes | 3 | 1999 | 790 | 0.090 |
Why?
|
| Aminoisobutyric Acids | 2 | 1988 | 39 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2000 | 2564 | 0.090 |
Why?
|
| Fatty Acids, Nonesterified | 5 | 2000 | 392 | 0.090 |
Why?
|
| Indians, North American | 2 | 1995 | 350 | 0.090 |
Why?
|
| Mitochondria | 4 | 1998 | 3584 | 0.090 |
Why?
|
| Ephedrine | 1 | 1990 | 52 | 0.090 |
Why?
|
| Hyperlipidemias | 4 | 2014 | 771 | 0.090 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 3 | 2002 | 135 | 0.090 |
Why?
|
| Terminology as Topic | 1 | 2017 | 1533 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 1997 | 1398 | 0.090 |
Why?
|
| Polymorphism, Genetic | 5 | 1996 | 4284 | 0.090 |
Why?
|
| Radioimmunoassay | 5 | 2000 | 866 | 0.090 |
Why?
|
| Growth Disorders | 1 | 1995 | 653 | 0.080 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2000 | 132 | 0.080 |
Why?
|
| Bone Density | 1 | 2002 | 3533 | 0.080 |
Why?
|
| Cyclic AMP | 3 | 2006 | 1455 | 0.080 |
Why?
|
| Germ-Free Life | 1 | 2009 | 187 | 0.080 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 751 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2004 | 553 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2007 | 1171 | 0.080 |
Why?
|
| Hospitals | 1 | 2023 | 3888 | 0.080 |
Why?
|
| Birth Weight | 1 | 1997 | 2097 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2013 | 11070 | 0.080 |
Why?
|
| Angiotensin II | 1 | 1992 | 848 | 0.080 |
Why?
|
| Information Dissemination | 1 | 2017 | 1128 | 0.080 |
Why?
|
| Body Composition | 6 | 2003 | 2416 | 0.080 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2001 | 617 | 0.080 |
Why?
|
| Motivation | 1 | 2019 | 1996 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2006 | 1527 | 0.080 |
Why?
|
| Cell Count | 3 | 2007 | 1835 | 0.080 |
Why?
|
| Pancreatitis | 1 | 2016 | 1098 | 0.080 |
Why?
|
| Point Mutation | 1 | 1994 | 1593 | 0.080 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 1999 | 361 | 0.080 |
Why?
|
| Neurogenesis | 2 | 2011 | 855 | 0.080 |
Why?
|
| Thyrotropin | 3 | 2001 | 832 | 0.080 |
Why?
|
| RNA Splicing | 2 | 1992 | 913 | 0.080 |
Why?
|
| Monocytes | 11 | 1989 | 2570 | 0.080 |
Why?
|
| Tryptophan | 1 | 1990 | 479 | 0.080 |
Why?
|
| Obesity, Morbid | 3 | 2002 | 1277 | 0.080 |
Why?
|
| Leadership | 1 | 2017 | 1371 | 0.080 |
Why?
|
| Disease Models, Animal | 4 | 2014 | 18125 | 0.080 |
Why?
|
| Genes | 4 | 1993 | 1845 | 0.080 |
Why?
|
| Potassium | 4 | 1988 | 1310 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2007 | 10747 | 0.070 |
Why?
|
| Oxidation-Reduction | 3 | 2014 | 2222 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 1998 | 1751 | 0.070 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1997 | 1851 | 0.070 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2008 | 169 | 0.070 |
Why?
|
| Alanine | 1 | 1990 | 603 | 0.070 |
Why?
|
| Tissue Distribution | 4 | 2009 | 2263 | 0.070 |
Why?
|
| Infant, Premature | 1 | 1997 | 2092 | 0.070 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2011 | 368 | 0.070 |
Why?
|
| Chemokine CCL7 | 1 | 2007 | 30 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 2690 | 0.070 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2007 | 47 | 0.070 |
Why?
|
| Granulosa Cell Tumor | 1 | 1988 | 72 | 0.070 |
Why?
|
| Biological Transport, Active | 6 | 1984 | 327 | 0.070 |
Why?
|
| Xanthine Dehydrogenase | 1 | 2007 | 17 | 0.070 |
Why?
|
| Precipitin Tests | 4 | 2004 | 814 | 0.070 |
Why?
|
| Biological Transport | 9 | 2000 | 2084 | 0.070 |
Why?
|
| Estrus | 2 | 1997 | 70 | 0.070 |
Why?
|
| Chemokine CXCL11 | 3 | 2001 | 43 | 0.070 |
Why?
|
| Time Factors | 10 | 2014 | 39873 | 0.070 |
Why?
|
| Blotting, Northern | 7 | 1999 | 1543 | 0.070 |
Why?
|
| Pregnancy | 10 | 2011 | 29742 | 0.070 |
Why?
|
| Endopeptidases | 2 | 1987 | 772 | 0.070 |
Why?
|
| Cell Transdifferentiation | 1 | 2007 | 185 | 0.070 |
Why?
|
| Kidney | 7 | 2010 | 7016 | 0.070 |
Why?
|
| RNA, Small Interfering | 4 | 2011 | 3433 | 0.070 |
Why?
|
| Muscle Cramp | 2 | 1989 | 34 | 0.070 |
Why?
|
| Drug Resistance | 3 | 2010 | 1593 | 0.070 |
Why?
|
| Receptors, Melanocortin | 3 | 2002 | 23 | 0.070 |
Why?
|
| Janus Kinase 2 | 2 | 2000 | 537 | 0.070 |
Why?
|
| Motor Activity | 3 | 2009 | 2686 | 0.070 |
Why?
|
| Fluorenes | 1 | 2007 | 157 | 0.070 |
Why?
|
| Anethole Trithione | 1 | 2005 | 1 | 0.070 |
Why?
|
| Fats | 1 | 2006 | 99 | 0.070 |
Why?
|
| Estradiol | 3 | 1998 | 1933 | 0.070 |
Why?
|
| Body Mass Index | 4 | 1998 | 12876 | 0.070 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1988 | 617 | 0.070 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 1 | 2005 | 36 | 0.070 |
Why?
|
| Sodium | 3 | 1982 | 1588 | 0.070 |
Why?
|
| Glucose Transporter Type 4 | 3 | 1996 | 240 | 0.070 |
Why?
|
| Rabbits | 3 | 2006 | 4771 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2006 | 203 | 0.060 |
Why?
|
| Species Specificity | 3 | 2002 | 2417 | 0.060 |
Why?
|
| Neural Pathways | 3 | 2006 | 3040 | 0.060 |
Why?
|
| Sodium Chloride | 2 | 2003 | 588 | 0.060 |
Why?
|
| Pyrrolidonecarboxylic Acid | 3 | 2000 | 65 | 0.060 |
Why?
|
| Hypertension | 3 | 2003 | 8503 | 0.060 |
Why?
|
| Gastroplasty | 1 | 2007 | 157 | 0.060 |
Why?
|
| Gene Targeting | 2 | 2001 | 837 | 0.060 |
Why?
|
| Animal Feed | 2 | 2004 | 112 | 0.060 |
Why?
|
| Ki-67 Antigen | 1 | 2007 | 631 | 0.060 |
Why?
|
| Feedback | 2 | 2000 | 791 | 0.060 |
Why?
|
| Amphetamine | 1 | 2006 | 224 | 0.060 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2006 | 370 | 0.060 |
Why?
|
| Receptor, Melanocortin, Type 4 | 2 | 2003 | 128 | 0.060 |
Why?
|
| Monoamine Oxidase | 1 | 2005 | 175 | 0.060 |
Why?
|
| Caffeine | 1 | 1990 | 701 | 0.060 |
Why?
|
| Ventral Tegmental Area | 1 | 2006 | 136 | 0.060 |
Why?
|
| Antibodies | 4 | 1996 | 2420 | 0.060 |
Why?
|
| Skin | 3 | 1998 | 4464 | 0.060 |
Why?
|
| Chemokine CXCL10 | 3 | 2001 | 316 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 1998 | 4020 | 0.060 |
Why?
|
| Rats, Inbred Strains | 6 | 1998 | 2090 | 0.060 |
Why?
|
| Arousal | 1 | 1991 | 1157 | 0.060 |
Why?
|
| Diabetes Mellitus, Lipoatrophic | 2 | 1983 | 9 | 0.060 |
Why?
|
| Exons | 8 | 1999 | 2387 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1991 | 1304 | 0.060 |
Why?
|
| United States | 3 | 2020 | 72140 | 0.060 |
Why?
|
| Satiation | 1 | 2005 | 83 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2007 | 1647 | 0.060 |
Why?
|
| DNA, Complementary | 3 | 1997 | 1991 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2013 | 550 | 0.060 |
Why?
|
| Anilides | 1 | 2007 | 409 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2020 | 3806 | 0.060 |
Why?
|
| Adult | 47 | 2017 | 219916 | 0.060 |
Why?
|
| Puberty | 2 | 1998 | 498 | 0.060 |
Why?
|
| Triglycerides | 6 | 2009 | 2450 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-fos | 4 | 2004 | 585 | 0.060 |
Why?
|
| Lipogenesis | 1 | 2006 | 210 | 0.060 |
Why?
|
| Adipogenesis | 1 | 2007 | 358 | 0.060 |
Why?
|
| Renin-Angiotensin System | 2 | 2003 | 733 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1988 | 701 | 0.060 |
Why?
|
| Tubulin | 1 | 2007 | 692 | 0.060 |
Why?
|
| Cytokines | 3 | 2006 | 7338 | 0.060 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2003 | 5 | 0.060 |
Why?
|
| Genetic Variation | 4 | 1995 | 6548 | 0.060 |
Why?
|
| Biological Evolution | 1 | 2009 | 1074 | 0.060 |
Why?
|
| Genes, Immediate-Early | 1 | 2004 | 102 | 0.060 |
Why?
|
| beta-Adrenergic Receptor Kinases | 1 | 2003 | 10 | 0.060 |
Why?
|
| Cytarabine | 1 | 2005 | 696 | 0.060 |
Why?
|
| Drug Synergism | 2 | 2006 | 1745 | 0.060 |
Why?
|
| Dynamin I | 1 | 2003 | 16 | 0.060 |
Why?
|
| Receptors, Calcitriol | 1 | 2006 | 359 | 0.050 |
Why?
|
| Uremia | 1 | 1984 | 201 | 0.050 |
Why?
|
| Placenta | 5 | 1989 | 1702 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2003 | 55 | 0.050 |
Why?
|
| Binding Sites | 7 | 2004 | 6036 | 0.050 |
Why?
|
| Dorsomedial Hypothalamic Nucleus | 2 | 2004 | 14 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2004 | 574 | 0.050 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2005 | 296 | 0.050 |
Why?
|
| Stomach | 1 | 2007 | 694 | 0.050 |
Why?
|
| Digestive System | 1 | 2004 | 244 | 0.050 |
Why?
|
| Arrestins | 1 | 2003 | 73 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 2003 | 113 | 0.050 |
Why?
|
| Guanosine Triphosphate | 2 | 1994 | 316 | 0.050 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2002 | 46 | 0.050 |
Why?
|
| Erythrocyte Membrane | 2 | 1982 | 439 | 0.050 |
Why?
|
| Bufo marinus | 2 | 1979 | 32 | 0.050 |
Why?
|
| Gluconeogenesis | 2 | 2011 | 185 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2004 | 2858 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2006 | 665 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2006 | 597 | 0.050 |
Why?
|
| Peptide Fragments | 3 | 2003 | 5098 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2006 | 6233 | 0.050 |
Why?
|
| Sirolimus | 2 | 2007 | 1533 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 1997 | 2753 | 0.050 |
Why?
|
| Threonine | 1 | 2003 | 270 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 2004 | 2433 | 0.050 |
Why?
|
| Body Temperature Regulation | 4 | 2003 | 286 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2004 | 2872 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 460 | 0.050 |
Why?
|
| Inflammation | 6 | 2016 | 10719 | 0.050 |
Why?
|
| Liver Cirrhosis | 3 | 2018 | 1930 | 0.050 |
Why?
|
| Neurites | 1 | 2004 | 390 | 0.050 |
Why?
|
| Enteric Nervous System | 1 | 2005 | 212 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 1895 | 0.050 |
Why?
|
| Graves Disease | 2 | 1981 | 238 | 0.050 |
Why?
|
| Blotting, Western | 5 | 2011 | 5031 | 0.050 |
Why?
|
| Isoquinolines | 1 | 2003 | 351 | 0.050 |
Why?
|
| Lipoprotein Lipase | 1 | 2001 | 133 | 0.050 |
Why?
|
| Viscera | 1 | 2001 | 138 | 0.050 |
Why?
|
| Environment | 1 | 2007 | 1118 | 0.050 |
Why?
|
| Food Deprivation | 2 | 1998 | 114 | 0.050 |
Why?
|
| Oncogenes | 1 | 1987 | 1221 | 0.050 |
Why?
|
| Sucrose | 1 | 1981 | 156 | 0.050 |
Why?
|
| Antibody Specificity | 2 | 2000 | 1060 | 0.050 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2001 | 61 | 0.050 |
Why?
|
| Lichen Planus | 1 | 2001 | 71 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2000 | 120 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 483 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 490 | 0.040 |
Why?
|
| Myasthenia Gravis | 2 | 1981 | 212 | 0.040 |
Why?
|
| Blotting, Southern | 4 | 1994 | 777 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 1998 | 818 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 1969 | 0.040 |
Why?
|
| Mitochondria, Liver | 1 | 2001 | 190 | 0.040 |
Why?
|
| Lamins | 1 | 2000 | 37 | 0.040 |
Why?
|
| RNA Interference | 2 | 2006 | 2836 | 0.040 |
Why?
|
| Receptors, CXCR3 | 1 | 2001 | 238 | 0.040 |
Why?
|
| 3T3 Cells | 4 | 2011 | 1084 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 835 | 0.040 |
Why?
|
| Isoenzymes | 2 | 2004 | 1686 | 0.040 |
Why?
|
| Enzyme Activation | 4 | 2005 | 3593 | 0.040 |
Why?
|
| Resistin | 1 | 2001 | 172 | 0.040 |
Why?
|
| Weight-Bearing | 1 | 2002 | 517 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2007 | 1230 | 0.040 |
Why?
|
| Cell Membrane | 9 | 2000 | 3680 | 0.040 |
Why?
|
| Restriction Mapping | 3 | 1997 | 852 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2004 | 663 | 0.040 |
Why?
|
| Mitochondria, Muscle | 1 | 2001 | 172 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2001 | 295 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 6 | 1989 | 9160 | 0.040 |
Why?
|
| Periodicity | 1 | 2001 | 348 | 0.040 |
Why?
|
| Thyroid Hormones | 2 | 2000 | 403 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2000 | 223 | 0.040 |
Why?
|
| HLA-DR Antigens | 1 | 2001 | 630 | 0.040 |
Why?
|
| Cardiac Glycosides | 1 | 1979 | 29 | 0.040 |
Why?
|
| Diet | 4 | 2006 | 8003 | 0.040 |
Why?
|
| Syntaxin 1 | 1 | 1999 | 30 | 0.040 |
Why?
|
| GAP-43 Protein | 1 | 1999 | 152 | 0.040 |
Why?
|
| Synaptophysin | 1 | 1999 | 139 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 2001 | 279 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2003 | 3709 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 1997 | 410 | 0.040 |
Why?
|
| Codon | 4 | 1994 | 602 | 0.040 |
Why?
|
| Coated Pits, Cell-Membrane | 1 | 1999 | 74 | 0.040 |
Why?
|
| Amphibian Venoms | 1 | 1978 | 5 | 0.040 |
Why?
|
| Lamin Type A | 1 | 2000 | 187 | 0.040 |
Why?
|
| Testosterone | 3 | 1998 | 2471 | 0.040 |
Why?
|
| Receptors, Somatotropin | 1 | 1999 | 58 | 0.040 |
Why?
|
| Nuclear Envelope | 1 | 2000 | 163 | 0.040 |
Why?
|
| Capillaries | 1 | 2002 | 744 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-1 | 2 | 2015 | 51 | 0.040 |
Why?
|
| Endocytosis | 1 | 2003 | 958 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 1999 | 258 | 0.040 |
Why?
|
| Molecular Mimicry | 1 | 1999 | 200 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2001 | 1705 | 0.040 |
Why?
|
| Lactones | 1 | 2000 | 317 | 0.040 |
Why?
|
| Nasal Mucosa | 3 | 1987 | 412 | 0.040 |
Why?
|
| Abdomen | 2 | 2001 | 1129 | 0.040 |
Why?
|
| Androgens | 2 | 1985 | 1291 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2002 | 1844 | 0.040 |
Why?
|
| Activity Cycles | 1 | 1998 | 47 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 5 | 1979 | 346 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2006 | 2472 | 0.040 |
Why?
|
| Weaning | 1 | 1998 | 103 | 0.040 |
Why?
|
| Prostaglandins, Synthetic | 1 | 1997 | 24 | 0.040 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1998 | 224 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 1176 | 0.040 |
Why?
|
| Astrocytes | 1 | 2005 | 1337 | 0.040 |
Why?
|
| Myocardium | 3 | 2001 | 4690 | 0.040 |
Why?
|
| Cerebral Ventricles | 1 | 2000 | 542 | 0.040 |
Why?
|
| Diet, Fat-Restricted | 1 | 2000 | 329 | 0.040 |
Why?
|
| Insulin Antibodies | 4 | 1981 | 30 | 0.040 |
Why?
|
| Cell Division | 3 | 1990 | 4459 | 0.040 |
Why?
|
| Antioxidants | 1 | 2005 | 1662 | 0.040 |
Why?
|
| Follicular Phase | 1 | 1998 | 143 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2001 | 1125 | 0.040 |
Why?
|
| Skin Physiological Phenomena | 1 | 1978 | 188 | 0.040 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2017 | 36 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2003 | 2057 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-2 | 2 | 2015 | 213 | 0.040 |
Why?
|
| Lymphocytes | 5 | 1979 | 2610 | 0.040 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 1998 | 240 | 0.040 |
Why?
|
| Carboxypeptidase H | 1 | 1996 | 9 | 0.040 |
Why?
|
| Chromans | 1 | 1997 | 117 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1987 | 2825 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 1997 | 26182 | 0.040 |
Why?
|
| Agouti Signaling Protein | 1 | 1996 | 23 | 0.040 |
Why?
|
| Adolescent | 16 | 1998 | 87888 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2006 | 2057 | 0.040 |
Why?
|
| Genotype | 2 | 2004 | 12945 | 0.030 |
Why?
|
| Meninges | 1 | 1998 | 197 | 0.030 |
Why?
|
| Dietary Carbohydrates | 1 | 1981 | 890 | 0.030 |
Why?
|
| Carboxypeptidases | 1 | 1996 | 154 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2002 | 1185 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 1611 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2000 | 1632 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 2470 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2017 | 622 | 0.030 |
Why?
|
| Anorexia | 1 | 1997 | 154 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2009 | 3245 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 1999 | 562 | 0.030 |
Why?
|
| Models, Immunological | 1 | 1998 | 513 | 0.030 |
Why?
|
| Transferases | 1 | 1996 | 72 | 0.030 |
Why?
|
| Farnesyltranstransferase | 1 | 1996 | 71 | 0.030 |
Why?
|
| Lighting | 1 | 1998 | 211 | 0.030 |
Why?
|
| Chromones | 1 | 1996 | 148 | 0.030 |
Why?
|
| Granulosa Cells | 2 | 1987 | 115 | 0.030 |
Why?
|
| Restraint, Physical | 1 | 1997 | 186 | 0.030 |
Why?
|
| Choroid Plexus | 1 | 1998 | 237 | 0.030 |
Why?
|
| Apoptosis | 1 | 2011 | 9468 | 0.030 |
Why?
|
| Infusions, Intraventricular | 1 | 2015 | 32 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2002 | 1018 | 0.030 |
Why?
|
| Luteinizing Hormone | 1 | 1998 | 820 | 0.030 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2017 | 156 | 0.030 |
Why?
|
| Glycogen | 3 | 1992 | 251 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 1994 | 11 | 0.030 |
Why?
|
| Phosphotransferases | 2 | 1993 | 302 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 1998 | 6209 | 0.030 |
Why?
|
| Injections, Intravenous | 3 | 2010 | 1378 | 0.030 |
Why?
|
| Epidermal Growth Factor | 2 | 2013 | 695 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 1997 | 437 | 0.030 |
Why?
|
| Growth | 1 | 1997 | 365 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 1999 | 1607 | 0.030 |
Why?
|
| Gene Amplification | 2 | 1989 | 1085 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 1984 | 1786 | 0.030 |
Why?
|
| Infusions, Subcutaneous | 1 | 2014 | 43 | 0.030 |
Why?
|
| Lipids | 2 | 2006 | 3326 | 0.030 |
Why?
|
| Chromosome Mapping | 3 | 1997 | 4624 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 1986 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 1997 | 637 | 0.030 |
Why?
|
| Complement C3a | 1 | 2014 | 66 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2004 | 1755 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1999 | 849 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2015 | 149 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 477 | 0.030 |
Why?
|
| Body Temperature | 2 | 2004 | 777 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 1978 | 832 | 0.030 |
Why?
|
| Growth Hormone | 3 | 1983 | 568 | 0.030 |
Why?
|
| Adrenal Glands | 1 | 1996 | 554 | 0.030 |
Why?
|
| Metformin | 2 | 1992 | 907 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2001 | 1333 | 0.030 |
Why?
|
| Mice, Inbred NOD | 2 | 2008 | 1825 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1991 | 416 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2014 | 271 | 0.030 |
Why?
|
| Genes, ras | 1 | 1996 | 654 | 0.030 |
Why?
|
| Lysosomes | 1 | 1999 | 919 | 0.030 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2013 | 18 | 0.030 |
Why?
|
| Hydrocortisone | 2 | 1998 | 1802 | 0.030 |
Why?
|
| Human Growth Hormone | 1 | 1998 | 638 | 0.030 |
Why?
|
| Psoriasis | 1 | 2001 | 938 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2001 | 1368 | 0.030 |
Why?
|
| Estrogens | 2 | 1998 | 1520 | 0.030 |
Why?
|
| Immune Sera | 2 | 1987 | 613 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2385 | 0.030 |
Why?
|
| Morpholines | 1 | 1996 | 580 | 0.030 |
Why?
|
| Anorexia Nervosa | 2 | 1997 | 1361 | 0.030 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1992 | 68 | 0.030 |
Why?
|
| Hepatitis | 1 | 2014 | 229 | 0.030 |
Why?
|
| Portal Vein | 1 | 1995 | 429 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2016 | 800 | 0.030 |
Why?
|
| Phenotype | 3 | 2006 | 16534 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 1993 | 543 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 1984 | 2457 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 5403 | 0.020 |
Why?
|
| Methylglucosides | 1 | 1991 | 35 | 0.020 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2011 | 63 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2002 | 2731 | 0.020 |
Why?
|
| Brain Stem | 1 | 1997 | 857 | 0.020 |
Why?
|
| Sympatholytics | 1 | 1971 | 82 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1996 | 778 | 0.020 |
Why?
|
| Vagina | 1 | 1997 | 838 | 0.020 |
Why?
|
| Epitopes | 3 | 1988 | 2502 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1996 | 1173 | 0.020 |
Why?
|
| Food | 2 | 1989 | 771 | 0.020 |
Why?
|
| Interferon-gamma | 2 | 2016 | 3156 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 1988 | 4876 | 0.020 |
Why?
|
| Cerebellum | 1 | 1998 | 1497 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 329 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2018 | 2292 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 1993 | 380 | 0.020 |
Why?
|
| ras Proteins | 1 | 1996 | 1049 | 0.020 |
Why?
|
| Exercise | 1 | 2007 | 5788 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2007 | 17768 | 0.020 |
Why?
|
| Isoproterenol | 1 | 2011 | 394 | 0.020 |
Why?
|
| Fetal Blood | 1 | 1997 | 1343 | 0.020 |
Why?
|
| Thymidine | 2 | 1992 | 299 | 0.020 |
Why?
|
| Protein Conformation | 2 | 1997 | 3966 | 0.020 |
Why?
|
| Cell Shape | 1 | 2011 | 371 | 0.020 |
Why?
|
| Sodium Glutamate | 1 | 1990 | 23 | 0.020 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2010 | 21 | 0.020 |
Why?
|
| Arteriosclerosis | 1 | 1995 | 1055 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1994 | 2176 | 0.020 |
Why?
|
| Integrases | 1 | 2013 | 516 | 0.020 |
Why?
|
| Models, Neurological | 1 | 1998 | 1757 | 0.020 |
Why?
|
| Sympathomimetics | 1 | 1990 | 56 | 0.020 |
Why?
|
| Retinoid X Receptors | 1 | 2010 | 91 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1992 | 1055 | 0.020 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1989 | 76 | 0.020 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 1989 | 75 | 0.020 |
Why?
|
| Tolazamide | 1 | 1989 | 2 | 0.020 |
Why?
|
| Cytochalasin B | 1 | 1989 | 74 | 0.020 |
Why?
|
| Arizona | 1 | 1989 | 107 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 308 | 0.020 |
Why?
|
| Half-Life | 1 | 1990 | 652 | 0.020 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1989 | 145 | 0.020 |
Why?
|
| Administration, Intranasal | 3 | 1990 | 471 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 3774 | 0.020 |
Why?
|
| Binding Sites, Antibody | 3 | 1979 | 337 | 0.020 |
Why?
|
| Age Factors | 1 | 2006 | 18357 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2012 | 414 | 0.020 |
Why?
|
| Phenytoin | 1 | 1989 | 188 | 0.020 |
Why?
|
| Radioligand Assay | 2 | 1981 | 366 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 1989 | 455 | 0.020 |
Why?
|
| Paralyses, Familial Periodic | 1 | 1988 | 13 | 0.020 |
Why?
|
| Nutritional Status | 1 | 1997 | 1607 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 614 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2011 | 1094 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 1989 | 869 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 754 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2012 | 780 | 0.020 |
Why?
|
| Blood | 1 | 1990 | 586 | 0.020 |
Why?
|
| Linear Models | 1 | 1998 | 5861 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1996 | 1725 | 0.020 |
Why?
|
| Absorption | 2 | 1987 | 243 | 0.020 |
Why?
|
| Genomic Library | 2 | 1999 | 189 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 2 | 1987 | 513 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 1990 | 862 | 0.020 |
Why?
|
| Fusidic Acid | 1 | 1987 | 15 | 0.020 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 4313 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1988 | 189 | 0.020 |
Why?
|
| Growth Substances | 1 | 1989 | 768 | 0.020 |
Why?
|
| Glycosylation | 1 | 1990 | 1095 | 0.020 |
Why?
|
| Organ Size | 2 | 2007 | 2252 | 0.020 |
Why?
|
| Hypokalemia | 1 | 1988 | 152 | 0.020 |
Why?
|
| DNA Probes | 3 | 1996 | 543 | 0.020 |
Why?
|
| Autoimmune Diseases | 4 | 1981 | 2244 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2011 | 986 | 0.020 |
Why?
|
| Neuroglia | 1 | 2013 | 944 | 0.020 |
Why?
|
| Aurothioglucose | 2 | 1996 | 11 | 0.020 |
Why?
|
| Cricetulus | 1 | 1989 | 815 | 0.020 |
Why?
|
| Fenofibrate | 1 | 2007 | 87 | 0.020 |
Why?
|
| Adrenalectomy | 1 | 1989 | 348 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 1997 | 3208 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2007 | 183 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2007 | 130 | 0.020 |
Why?
|
| Drug Combinations | 2 | 1990 | 2020 | 0.020 |
Why?
|
| Clorgyline | 1 | 2005 | 14 | 0.020 |
Why?
|
| Interleukin-2 | 2 | 2007 | 1888 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1997 | 4215 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1996 | 2895 | 0.020 |
Why?
|
| RNA | 3 | 1993 | 2716 | 0.020 |
Why?
|
| Mitogens | 1 | 1986 | 230 | 0.020 |
Why?
|
| Middle Aged | 18 | 1996 | 219560 | 0.020 |
Why?
|
| Introns | 2 | 1999 | 978 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 1878 | 0.020 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2005 | 155 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2011 | 1168 | 0.020 |
Why?
|
| Child Development | 1 | 1997 | 2285 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 2 | 1991 | 1972 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2000 | 7985 | 0.010 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 1186 | 0.010 |
Why?
|
| Calcitriol | 1 | 2006 | 297 | 0.010 |
Why?
|
| Tristetraprolin | 1 | 2004 | 38 | 0.010 |
Why?
|
| Receptors, Drug | 1 | 1984 | 157 | 0.010 |
Why?
|
| Hypertrophy | 2 | 1989 | 555 | 0.010 |
Why?
|
| DNA Replication | 1 | 1991 | 1410 | 0.010 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 14481 | 0.010 |
Why?
|
| Massachusetts | 1 | 2017 | 8823 | 0.010 |
Why?
|
| Extremities | 1 | 1989 | 865 | 0.010 |
Why?
|
| Ovarian Follicle | 1 | 1985 | 244 | 0.010 |
Why?
|
| Lithium Chloride | 1 | 2004 | 82 | 0.010 |
Why?
|
| Deoxycholic Acid | 1 | 1983 | 53 | 0.010 |
Why?
|
| Hyperphagia | 1 | 2004 | 139 | 0.010 |
Why?
|
| Sciatic Nerve | 1 | 1987 | 613 | 0.010 |
Why?
|
| Bile Acids and Salts | 1 | 1985 | 383 | 0.010 |
Why?
|
| Insulin Antagonists | 1 | 1983 | 17 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 318 | 0.010 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2003 | 85 | 0.010 |
Why?
|
| Lipopolysaccharides | 2 | 2004 | 2204 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2007 | 1084 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2009 | 1507 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1997 | 12262 | 0.010 |
Why?
|
| Immunoglobulin G | 3 | 1988 | 4540 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 2005 | 552 | 0.010 |
Why?
|
| Hypolipidemic Agents | 1 | 2007 | 609 | 0.010 |
Why?
|
| Pedigree | 1 | 1990 | 4578 | 0.010 |
Why?
|
| Child | 9 | 1998 | 79813 | 0.010 |
Why?
|
| Protein Binding | 2 | 1996 | 9312 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1985 | 662 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1989 | 6127 | 0.010 |
Why?
|
| Thyroid Function Tests | 1 | 1983 | 289 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 568 | 0.010 |
Why?
|
| Actins | 1 | 1989 | 2049 | 0.010 |
Why?
|
| Cholesterol | 2 | 2004 | 2901 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 412 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1982 | 361 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 597 | 0.010 |
Why?
|
| Age of Onset | 1 | 2008 | 3298 | 0.010 |
Why?
|
| Amenorrhea | 1 | 1985 | 480 | 0.010 |
Why?
|
| Leukocytes | 1 | 1989 | 2025 | 0.010 |
Why?
|
| Receptors, Thyrotropin | 1 | 1981 | 45 | 0.010 |
Why?
|
| Aerosols | 1 | 1983 | 631 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1989 | 3734 | 0.010 |
Why?
|
| Blood Pressure | 2 | 1997 | 8453 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1980 | 201 | 0.010 |
Why?
|
| Cations | 1 | 1980 | 238 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2673 | 0.010 |
Why?
|
| Receptors, Cholinergic | 1 | 1981 | 241 | 0.010 |
Why?
|
| Digitalis Glycosides | 1 | 1979 | 47 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2007 | 1358 | 0.010 |
Why?
|
| Secretory Rate | 1 | 1998 | 81 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2003 | 575 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2000 | 333 | 0.010 |
Why?
|
| RNA Probes | 1 | 1998 | 111 | 0.010 |
Why?
|
| Skinfold Thickness | 1 | 1998 | 158 | 0.010 |
Why?
|
| Infertility, Female | 1 | 1984 | 759 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1992 | 1743 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1998 | 136 | 0.010 |
Why?
|
| Plasmapheresis | 1 | 1979 | 206 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1971 | 4158 | 0.010 |
Why?
|
| Neuromuscular Junction | 1 | 1981 | 403 | 0.010 |
Why?
|
| Prevalence | 1 | 1995 | 15646 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1985 | 1317 | 0.010 |
Why?
|
| Estrus Detection | 1 | 1997 | 3 | 0.010 |
Why?
|
| Biological Availability | 2 | 1990 | 390 | 0.010 |
Why?
|
| Autoradiography | 1 | 1998 | 730 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 1998 | 439 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 5490 | 0.010 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 1997 | 93 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1978 | 405 | 0.010 |
Why?
|
| Fingers | 1 | 1980 | 506 | 0.010 |
Why?
|
| Nonsuppressible Insulin-Like Activity | 1 | 1977 | 1 | 0.010 |
Why?
|
| Thyroid Diseases | 1 | 1981 | 386 | 0.010 |
Why?
|
| Biopsy | 1 | 1989 | 6768 | 0.010 |
Why?
|
| Entropy | 1 | 1998 | 210 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13468 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 1694 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1998 | 3801 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1979 | 818 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1997 | 62 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 2008 | 10171 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2008 | 3485 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1997 | 276 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2006 | 2907 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1976 | 297 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1978 | 444 | 0.010 |
Why?
|
| Blood Specimen Collection | 1 | 1998 | 238 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2000 | 1032 | 0.010 |
Why?
|
| Homozygote | 1 | 2001 | 1788 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15785 | 0.010 |
Why?
|
| Alleles | 3 | 1992 | 6895 | 0.010 |
Why?
|
| Uncoupling Agents | 1 | 1996 | 46 | 0.010 |
Why?
|
| Allosteric Regulation | 1 | 1977 | 426 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1976 | 645 | 0.010 |
Why?
|
| Curriculum | 1 | 2009 | 3717 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1999 | 598 | 0.010 |
Why?
|
| Glucose Transporter Type 1 | 1 | 1996 | 186 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 1997 | 378 | 0.010 |
Why?
|
| Prealbumin | 1 | 1997 | 222 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1988 | 3586 | 0.010 |
Why?
|
| Immunoassay | 1 | 1979 | 746 | 0.010 |
Why?
|
| Cushing Syndrome | 1 | 1997 | 241 | 0.010 |
Why?
|
| Menstruation | 1 | 1997 | 307 | 0.010 |
Why?
|
| Lactates | 1 | 1996 | 404 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1981 | 1368 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1998 | 1539 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 2797 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1998 | 1249 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1987 | 2185 | 0.010 |
Why?
|
| Quality Control | 1 | 1997 | 825 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 783 | 0.010 |
Why?
|
| Physical Fitness | 1 | 1998 | 732 | 0.010 |
Why?
|
| Lymphokines | 1 | 1997 | 926 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1978 | 1167 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1976 | 859 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 1997 | 1130 | 0.010 |
Why?
|
| Hexoses | 1 | 1992 | 29 | 0.010 |
Why?
|
| Microtubules | 1 | 1978 | 1072 | 0.010 |
Why?
|
| Wales | 1 | 1992 | 86 | 0.010 |
Why?
|
| Complement Factor B | 1 | 1992 | 72 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 1996 | 1006 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1998 | 1846 | 0.010 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 1992 | 93 | 0.010 |
Why?
|
| Interleukins | 1 | 1997 | 783 | 0.010 |
Why?
|
| 3-O-Methylglucose | 1 | 1991 | 37 | 0.010 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1991 | 37 | 0.010 |
Why?
|
| Phenoxybenzamine | 1 | 1971 | 53 | 0.010 |
Why?
|
| Phentolamine | 1 | 1971 | 102 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2000 | 2443 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1977 | 3069 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 1997 | 1174 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1997 | 1207 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1998 | 2666 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1971 | 174 | 0.010 |
Why?
|
| Lactic Acid | 1 | 1996 | 1133 | 0.010 |
Why?
|
| Solubility | 2 | 1985 | 1087 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 9405 | 0.010 |
Why?
|
| Temperature | 1 | 1977 | 2219 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1993 | 459 | 0.010 |
Why?
|
| Streptozocin | 1 | 1990 | 193 | 0.010 |
Why?
|
| Spleen | 1 | 1996 | 2296 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1990 | 291 | 0.010 |
Why?
|
| Aged | 5 | 1996 | 168217 | 0.010 |
Why?
|
| Erythroid Precursor Cells | 1 | 1990 | 211 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 1991 | 352 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1990 | 763 | 0.010 |
Why?
|
| Colon | 1 | 1997 | 1788 | 0.010 |
Why?
|
| GTPase-Activating Proteins | 1 | 1992 | 474 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 1995 | 15396 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1996 | 1788 | 0.000 |
Why?
|
| Cell Transformation, Viral | 1 | 1990 | 526 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1998 | 6353 | 0.000 |
Why?
|
| Carbohydrate Metabolism | 1 | 1989 | 262 | 0.000 |
Why?
|
| Clone Cells | 1 | 1991 | 1660 | 0.000 |
Why?
|
| Nucleic Acid Conformation | 1 | 1991 | 895 | 0.000 |
Why?
|
| Buffers | 1 | 1987 | 144 | 0.000 |
Why?
|
| Affinity Labels | 1 | 1987 | 107 | 0.000 |
Why?
|
| Echocardiography | 1 | 1999 | 4962 | 0.000 |
Why?
|
| Plasmids | 1 | 1992 | 2275 | 0.000 |
Why?
|
| Ventricular Function, Left | 1 | 1999 | 3858 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1971 | 1400 | 0.000 |
Why?
|
| Bone and Bones | 1 | 1997 | 2560 | 0.000 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1993 | 1356 | 0.000 |
Why?
|
| Pharmaceutical Vehicles | 1 | 1985 | 57 | 0.000 |
Why?
|
| Stem Cells | 1 | 1998 | 3521 | 0.000 |
Why?
|
| Heart Rate | 1 | 1997 | 4166 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1971 | 1557 | 0.000 |
Why?
|
| Organ Culture Techniques | 1 | 1987 | 795 | 0.000 |
Why?
|
| Hemolysis | 1 | 1987 | 423 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1989 | 2210 | 0.000 |
Why?
|
| Sheep | 1 | 1987 | 1441 | 0.000 |
Why?
|
| Cell Membrane Permeability | 1 | 1985 | 575 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1997 | 8554 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1990 | 4839 | 0.000 |
Why?
|
| Insulin, Long-Acting | 1 | 1981 | 58 | 0.000 |
Why?
|
| Models, Structural | 1 | 1981 | 341 | 0.000 |
Why?
|
| Antibody Affinity | 1 | 1981 | 245 | 0.000 |
Why?
|
| Fertilization in Vitro | 1 | 1987 | 1292 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1979 | 384 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1981 | 1433 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 1998 | 25953 | 0.000 |
Why?
|
| Algorithms | 1 | 1997 | 13959 | 0.000 |
Why?
|
| Neoplasms | 1 | 1985 | 22030 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1998 | 13591 | 0.000 |
Why?
|
| Glycolysis | 1 | 1978 | 826 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1985 | 12951 | 0.000 |
Why?
|
| Sex Factors | 1 | 1976 | 10505 | 0.000 |
Why?
|